Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Association between the CD24 Ala57Val polymorphism and risk for multiple sclerosis and systemic lupus erythematosus: a meta-analysis.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
Deletion of Mitochondrial Anchoring Protects Dysmyelinating Shiverer: Implications for Progressive MS.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.
The role of chromogranin B in an animal model of multiple sclerosis.
Multiple sclerosis and mitochondrial gene variations: A review.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
[Is it always useful to perform lumbar puncture for the diagnosis of multiple sclerosis? No].
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Targeting molecules to medicine with mTOR, autophagy, and neurodegenerative disorders.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
How to make an oligodendrocyte.
The progress of cognitive decline in newly diagnosed MS patients.
Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
Genetic burden in multiple sclerosis families.
Multiple sclerosis.
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
Relapsing inappropriate antidiuretic hormone secretion in an anti-aquaporin-4 antibody positive paediatric patient.
Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply.
Selected health behaviors moderate the progression of functional limitations in persons with multiple sclerosis: Eleven years of annual follow-up.
Pages
« first
‹ previous
…
436
437
438
439
440
441
442
443
444
…
next ›
last »